Ramtin Mojtahedi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramtin Mojtahedi has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amber L. Simpson
School of Computing, Queen’s University, Kingston, Canada
5 shared publications - Mohammad Hamghalam
School of Computing, Queen's University, Kingston, ON, Canada; Department of Electrical Engineering, Qa.C., Islamic Azad University, Qazvin, Iran
4 shared publications - Richard Kinh Gian Do
Department of Radiology Memorial Sloan Kettering Cancer Center New York New York USA
4 shared publications - William Robert Jarnagin
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA
2 shared publications - Christian Muise
Queen's University Kingston Canada
1 shared publication - E. Claire Bunker
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada
1 shared publication
Latest Publications
- 1 January 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 10 (1) , e2500135
Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification
PURPOSE: It is essential to detect and segment liver tumors to guide treatment and track disease progression. To reduce the need for large annotated data sets, we present an end-to-end pipeline that uses self-supervised pretraining to improve segmentation and then classifies tumor types with a separate pretrained classifier applied to the segmented tumor regions. METHODS: First, we pretrained the encoder of a transformer-based network using a self-supervised approach on unlabeled abdominal computed tomography images. Subsequently, we fine-tuned the segmentation network to segment the liver and tumors, and the tumor regions were classified using a pretrained convolutional neural network (Inception-v3 architecture) as intrahepatic cholangiocarcinoma (ICC), hepatocellular carcinoma (HCC), or colorectal liver metastases (CRLMs). We evaluated 459 images (155 HCC, 107 ICC, 197 CRLM). For external testing, we used an independent public data set (n = 40). RESULTS: Averaged across HCC, ICC, and CRLM, in comparison with a supervised baseline (no pretraining), self-supervised pretraining improved the liver Dice similarity coefficient (DSC) by 6.4 percentage points and reduced the 95th-percentile Hausdorff distance (HD 95 ) by 32.97 mm. For tumors, the DSC increased by 6.0 percentage points and the HD 95 decreased by 3.2 mm. Tumor type classification achieved AUC 0.98 (95% CI, 0.96 to 1.00) and accuracy 96% (95% CI, 92% to 99%). Segmentation performance on the external data was close to the internal cohort with tumor DSC 0.73, intersection over union (IoU) 0.60, and HD 95 30.98 mm and liver DSC 0.91, IoU 0.83, and HD 95 29.67 mm. CONCLUSION: The proposed self-supervised, end-to-end pipeline improves liver tumor segmentation and provides accurate tumor type classification, supporting reliable radiologic assessment, treatment planning, and improved prognostication for patients with liver cancer.
- 1 January 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 10 (1) , e2500135
Self-Supervised Transformer-Based Pipeline for Liver Tumor Segmentation and Type Classification
PURPOSE: It is essential to detect and segment liver tumors to guide treatment and track disease progression. To reduce the need for large annotated data sets, we present an end-to-end pipeline that uses self-supervised pretraining to improve segmentation and then classifies tumor types with a separate pretrained classifier applied to the segmented tumor regions. METHODS: First, we pretrained the encoder of a transformer-based network using a self-supervised approach on unlabeled abdominal computed tomography images. Subsequently, we fine-tuned the segmentation network to segment the liver and tumors, and the tumor regions were classified using a pretrained convolutional neural network (Inception-v3 architecture) as intrahepatic cholangiocarcinoma (ICC), hepatocellular carcinoma (HCC), or colorectal liver metastases (CRLMs). We evaluated 459 images (155 HCC, 107 ICC, 197 CRLM). For external testing, we used an independent public data set (n = 40). RESULTS: Averaged across HCC, ICC, and CRLM, in comparison with a supervised baseline (no pretraining), self-supervised pretraining improved the liver Dice similarity coefficient (DSC) by 6.4 percentage points and reduced the 95th-percentile Hausdorff distance (HD 95 ) by 32.97 mm. For tumors, the DSC increased by 6.0 percentage points and the HD 95 decreased by 3.2 mm. Tumor type classification achieved AUC 0.98 (95% CI, 0.96 to 1.00) and accuracy 96% (95% CI, 92% to 99%). Segmentation performance on the external data was close to the internal cohort with tumor DSC 0.73, intersection over union (IoU) 0.60, and HD 95 30.98 mm and liver DSC 0.91, IoU 0.83, and HD 95 29.67 mm. CONCLUSION: The proposed self-supervised, end-to-end pipeline improves liver tumor segmentation and provides accurate tumor type classification, supporting reliable radiologic assessment, treatment planning, and improved prognostication for patients with liver cancer.
- Open Access
- 1 January 2026
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 13 (01) , 1-15
Radiomic signatures from baseline CT predict chemotherapy response in unresectable colorectal liver metastases
PurposeColorectal cancer is the third most common cancer globally, with a high mortality rate due to metastatic progression, particularly in the liver. Surgical resection remains the main curative treatment, but only a small subset of patients is eligible for surgery at diagnosis. For patients with initially unresectable colorectal liver metastases (CRLM), neoadjuvant chemotherapy can downstage tumors, potentially making surgery feasible. We investigate whether radiomic signatures—quantitative imaging biomarkers derived from baseline computed tomography (CT) scans—can noninvasively predict chemotherapy response in patients with unresectable CRLM, offering a pathway toward personalized treatment planning.ApproachWe used radiomics combined with a stacking classifier (SC) to predict treatment outcome. Baseline CT imaging data from 355 patients with initially unresectable CRLM were analyzed using two regions of interest (ROIs) separately (all tumors in the liver and the largest tumor by volume). From each ROI, 107 radiomic features were extracted. The dataset was split into training and testing sets, and multiple machine learning models were trained and integrated via stacking to enhance prediction. Logistic regression coefficients were used to derive radiomic signatures.ResultsThe SC achieved strong predictive performance, with an area under the receiver operating characteristic curve of up to 0.77 for response prediction. Logistic regression identified 12 and 7 predictive features for treatment response in all tumors and the largest tumor ROIs, respectively.ConclusionOur findings demonstrate that radiomic features from baseline CT scans can serve as robust, interpretable biomarkers for predicting chemotherapy response, offering insights to guide personalized treatment in unresectable CRLM.
- 1 January 2026
- Published by SPIE-Intl Soc Optical Eng in Journal of Medical Imaging
- Vol. 13 (01) , 1-15
Open AccessRadiomic signatures from baseline CT predict chemotherapy response in unresectable colorectal liver metastases
PurposeColorectal cancer is the third most common cancer globally, with a high mortality rate due to metastatic progression, particularly in the liver. Surgical resection remains the main curative treatment, but only a small subset of patients is eligible for surgery at diagnosis. For patients with initially unresectable colorectal liver metastases (CRLM), neoadjuvant chemotherapy can downstage tumors, potentially making surgery feasible. We investigate whether radiomic signatures—quantitative imaging biomarkers derived from baseline computed tomography (CT) scans—can noninvasively predict chemotherapy response in patients with unresectable CRLM, offering a pathway toward personalized treatment planning.ApproachWe used radiomics combined with a stacking classifier (SC) to predict treatment outcome. Baseline CT imaging data from 355 patients with initially unresectable CRLM were analyzed using two regions of interest (ROIs) separately (all tumors in the liver and the largest tumor by volume). From each ROI, 107 radiomic features were extracted. The dataset was split into training and testing sets, and multiple machine learning models were trained and integrated via stacking to enhance prediction. Logistic regression coefficients were used to derive radiomic signatures.ResultsThe SC achieved strong predictive performance, with an area under the receiver operating characteristic curve of up to 0.77 for response prediction. Logistic regression identified 12 and 7 predictive features for treatment response in all tumors and the largest tumor ROIs, respectively.ConclusionOur findings demonstrate that radiomic features from baseline CT scans can serve as robust, interpretable biomarkers for predicting chemotherapy response, offering insights to guide personalized treatment in unresectable CRLM.
- 18 July 2023
- Published by Springer Nature
- p. 195-204
Multi-modal Brain Tumour Segmentation Using Transformer with Optimal Patch Size
- 18 July 2023
- Published by Springer Nature
- p. 195-204
Multi-modal Brain Tumour Segmentation Using Transformer with Optimal Patch Size
- 1 January 2023
- Published by Springer Nature
- p. 311-321
Leveraging Contrastive Learning with SimSiam for the Classification of Primary and Secondary Liver Cancers
- 1 January 2023
- Published by Springer Nature
- p. 311-321
Leveraging Contrastive Learning with SimSiam for the Classification of Primary and Secondary Liver Cancers
- 12 October 2022
- Published by Springer Nature
- p. 110-120
Towards Optimal Patch Size in Vision Transformers for Tumor Segmentation
- 12 October 2022
- Published by Springer Nature
- p. 110-120
Towards Optimal Patch Size in Vision Transformers for Tumor Segmentation